Chemical Constituents and Tyrosinase Inhibitory Activity of Aqueous Fraction of the Leaves of Morus alba L. from Vietnam

Authors

  • Loi Vu Duc School of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam

DOI:

https://doi.org/10.37591/rrjodfdp.v4i3.81

Abstract

The mulberry has been widely cultivated to feed silkworms. The leaves of mulberry have been used in traditional medicine as an analgesic, antitussive, cathartic, diuretic. In this study we have isolated three compounds (LC1-3) by chromatographic methods from the Mulberry leaves (Morus alba L.) collected in Thai Nguyen province, Vietnam. These compounds were identified as: Kaempferol-3,7-di-O-α-L-rhamnopyranoside (LC1), 7,4’-dihydroxy-5,3’-dimethoxyflavone (LC2), (S)-5,5’,7-trihydroxy-2’,4’-dimethoxy-6-methylflavanone (LC3). Their structures were elucidated by spectroscopic methods, including MS and NMR. Compound LC3 was isolated from Mulberry leaves for the first time. These compounds were evaluated the tyrosinase inhibitory activity in vitro. Our data showed that compound LC3 has potential tyrosinase inhibitory effects with IC50 values of 15.48 ± 2.96 µg/mL.

 

Keyword: Morus alba L., tyrosinase inhibitors, Kaempferol-3,7-di-O-α-L-rhamnopyranoside, 7,4’-dihydroxy-5,3’-dimethoxyflavone,(S)-5,5’,7-trihydroxy-2’,4’-dimethoxy-6-methylflavanone.

 

Cite this Article

Loi Vu Duc, Tung Bui Thanh, Huong Le Thi Thu et al. Chemical Constituents and Tyrosinase Inhibitory Activity of Aqueous Fraction of the Leaves of Morus alba L. from Vietnam. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2017; 4(3): 12–17p.

Downloads

Published

2018-04-03

Issue

Vol. 4 No. 3 (2017)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.